Patients of non-small cell lung cancer are also at risk of the disease spreading to their brains. Photo: AP/ Andy Wong

New lung cancer drug can prolong lives of late-stage patients, study led by Hong Kong expert finds

Renowned oncologist Tony Mok says US Food and Drug Administration is expected to approve the use of experimental drug dacomitinib ‘in the near future’

Topic |   Hong Kong cancer therapy

TOP PICKS

Patients of non-small cell lung cancer are also at risk of the disease spreading to their brains. Photo: AP/ Andy Wong
READ FULL ARTICLE